Home / Import refusals / NUV-3881703-0/70002/1

FDA Import Refusal NUV-3881703-0/70002/1 — GlaxoSmithKline, LLC.

GlaxoSmithKline, LLC. — FEI 3004055938

The FDA refused shipment NUV-3881703-0/70002/1 from GlaxoSmithKline, LLC. (United States) on February 24, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 24, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
118

Recent inspections

  • 1211050 (NAI Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043309 (VAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927643 (NAI Fri May 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730716 (NAI Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-0333205-3/10002/1 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-9324952-1/30002/1 (Tue Jun 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9318923-9/110002/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9449370-5/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1894214-1/10003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources